The Cardiovascular Technology Leadership (CVT) program began as a joint venture with the Health Science Center at Prisma Health (HSCPH) and Clemson University’s College of Behavioral, Social and Health Sciences in 2011 with the goal of producing graduates who are competent in 2 fields of ultrasound. This program transitioned in June 2022 to a unique undergraduate collaboration between Prisma Health and multiple academic universities within South Carolina to provide students the opportunity to obtain a certificate in cardiovascular sonography, which completes a Bachelor of Science degree in Cardiovascular Technology/Imaging or compliments an already earned Associate or Bachelor degree. This provides more opportunities for students to be a part of this highly successful program.
The CVT program has a proven track record of training knowledgeable and technically advanced cardiovascular sonographers. Students receive quality didactic and practical instruction with CVT educators in conjunction with immersive clinical experience under the supervision of highly trained preceptors at various sites within the Prisma Health network. By graduation, students take both the Vascular Technology and Adult Echocardiography board exams through the American Registry for Diagnostic Medical Sonography (ARDMS) and emerge ready to make an immediate impact on quality patient care with nationally accepted certifications in both fields of ultrasound.
The program has secured continuing programmatic accreditation through the Commission on Accreditation of Allied Health Education Programs (CAAEHP) in adult echocardiography and noninvasive vascular testing through January 2029. It is also licensed by the South Carolina Commission on Higher Education (SCCHE).
For more information, please visit CVT Leadership Program.
Our state-of-the-art surgical training and innovation laboratory is integral to training residents, fellows and surgeons. Specialized commercial device manufacturers and distributors also find this space optimal for courses and medical professional workshops. We also work closely with Clemson Bioengineering to provide a cadaveric facility for academic exploration and product development.
We have a collaborative study with Steadman Hawkins physicians, Clemson bioengineers, and industry to measure the micro-motion of an implant for reverse shoulder arthroplasty. Thirty-six custom-made saw bones were implanted with varied reverse baseplates, screws, and heads. The next step is to cycle them on Clemson's Instron machine until failure.
